Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.

TSX:TH - Post by User

Theratechnologies Inc > Go to hell

<< Previous

Bullboard Posts

Next >>

Comment by Jane101on Jul 09, 2022 7:21pm

252 Views

Post# 34813267

RE:RE:RE:RE:RE:Go to hell

Have either of you actually read your posts? They are bitter and angry and downright nasty. I am an investor just like you but I clearly read the RISKS associated with companies like this.

If you can do a better job why don't you?

There's a bunch of weirdos here that look like a bunch of jealous losers.

Also Greed and Gluttony are deadly since incase that sanctimonious idiot spce didn't know. He failed his duty to sell and take profits when he could so he blames everyone else. As Michael Jackson sang Start with the Man in the Mirror.

<< Previous

Bullboard Posts

Next >>

Advancing flagship Ishkõday Gold Project in Ontario